Therapeutic opportunities for regulatory T cell enhancing approaches.

The immune system plays a critical role in protecting the host against infection, but is subject to numerous levels of control that are necessary to prevent pathological, tissue damaging responses. Inappropriate inflammatory immune responses to self-antigens, innocuous commensal microorganisms or environmental antigens can lead to chronic, debilitating and degenerative diseases. Regulatory T cells have an essential, non-redundant and dominant function in preventing pathological immune responses, as shown by the development of systemic fatal autoimmunity in humans and animals with a genetic deficiency in regulatory T cells. In addition to controlling immune responses, there is a growing understanding that regulatory T cells also contribute directly to tissue homeostasis by promoting tissue regeneration and repair. For these reasons, the prospect of enhancing regulatory T cell numbers and/or function in patients represents an appealing therapeutic opportunity with potential applications in many diseases, including some where the pathological role of the immune system has only recently been recognised. Approaches to enhance regulatory T cells are now starting to be explored in clinical studies in humans. This review series brings together papers highlighting the Treg enhancing approaches that are most advanced clinically and examples of therapeutic opportunities based on our growing understanding of regulatory T cell functions.